Biosciences, a segment of BD (Becton, Dickinson and Company), has announced the spring 2011 winners of its Research Grant Program.
An independent panel of scientists selected the winners. Each recipient will receive a $10,000 grant of research reagents to help them conduct their studies.
The winners of the BD Biosciences Research Grant Program for the spring 2011 cycle are:
Richard Robinson, Ph.D., Assistant Professor, Medical College of Wisconsin, studies the effect of interleukin-12 receptor beta1 (IL12Rbeta1), a receptor generated by multiple immune cells that spans the cell membrane and binds to the p40-domain of IL 12 and IL 23, and IL 12p40 homodimer.
Christopher Grigsby, a Ph.D. candidate at Duke University, is engineering polymeric nanocomplexes for oral delivery of therapeutic genes.
Michael Sheard, Ph.D., Director, Flow Cytometry Core Facility, Children's Hospital Los Angeles, is studying natural killer cell-based immunotherapy for neuroblastoma.
Flavia Pereira, Ph.D., post-doctoral fellow at the University of Connecticut Health Center, is studying the involvement of immune system cells involved in healing after a myocardial infarction.
Doris Lambracht-Washington, Ph.D., Assistant Instructor, University of Texas Southwestern Medical Center, is developing a preclinical-stage vaccine for treating and preventing Alzheimer's disease (AD).
Dean Lee, M.D., Ph.D., Assistant Professor, University of Texas MD Anderson Cancer Center, investigates adoptive natural killer (NK) cell immunotherapy for treating cancer.
Yael Korin, Ph.D., Associated Researcher, UCLA Immunogenetics Center, will identify and validate immunological biomarkers in peripheral blood that may help predict tolerance in pediatric liver transplant recipients.